Education Featured Article
October 11, 2012
MEDL Mobile and Marlee Matlin Release Educational American Sign Language App
By Deepika Mala, TMCnet Contributor
Marlee Matlin, Academy Award-winning actress, has recently collaborated with MEDL Mobile, Inc. a pioneer in the creation, development, marketing and monetization of mobile apps to launch an educational American Sign Language app, called "Marlee Signs".
A user, with the help of "Marlee Signs" is able to learn the fundamentals of American Sign Language, from signed alphabet and basic vocabulary to common expressions in everyday life.
The app features high quality videos which show Marlee Matlin demonstrating the lessons. The “Spell” feature of the app allows users to get the spelling of any word in ASL by typing in a word and watching Marlee sign it back to them. Users are also allowed to watch any video in slow motion for greater detail and learn at their own pace by breaking down the lessons into individual videos.
"Working with Marlee Matlin has been a lot of fun! She was hysterical to work with on the set," said Dave Swartz, MEDL Co-founder and CCO, in a statement. "We believe that Marlee's breakthrough appeal will help introduce ASL to a broad new audience through the iPhone (News - Alert) and iPad."
"I wanted to create a simple, visual presentation of American Sign Language vocabulary that's the next best thing to taking a class," Marlee stated. "It's a great starting point for learning ASL the way it should - visually, in full motion, and not just static images on a page. It's not a substitute for taking a sign language class but I think it's the next best thing!"
In related TMC (News - Alert) news, MEDL Mobile, Inc. and famous hypnotist, Tyzen have released a family of mobile lessons designed to effectively deal with common problems such as losing weight, stress, quitting smoking and building confidence.
Edited by Brooke Neuman
LATEST EDUCATION NEWS
Galleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic